Get the Stockscreener App
2.17
6.37%
0.13
Pre-market:
2.25
0.08
+3.69%
Microbot Medical Inc stock is traded at $2.17, with a volume of 4.51M.
It is up +6.37% in the last 24 hours and down -23.59% over the past month.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
See More
Previous Close:
$2.04
Open:
$2.05
24h Volume:
4.51M
Relative Volume:
1.61
Market Cap:
$60.83M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-1.8083
EPS:
-1.2
Net Cash Flow:
$-9.21M
1W Performance:
+17.30%
1M Performance:
-23.59%
6M Performance:
+126.47%
1Y Performance:
+80.83%
1-Day Range:
$1.97
$2.34
1-Week Range:
$1.71
$2.34
52-Week Range:
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.17 | 60.83M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Microbot Medical (NASDAQ: MBOT) Announces Acceptance of Late-Breaking Abstract for SIR Annual MeetingOn February 4, 2025, Microbot Medical Inc., a developer of the LIBERTY® Endovascular Robotic System, disclosed the acceptance of a late-breakin - Defense World
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical Files Prospectus Relates To Resale From Time To Time Of Up To 15.97 Million Shares By Selling Stockholders - Marketscreener.com
Microbot Medical Presents LIBERTY System at Radiology Event - TipRanks
Microbot Medical® Announces Late-Breaking Abstract - GlobeNewswire
Microbot Medical to Present Groundbreaking LIBERTY Robot Trial Data at SIR 2025 | MBOT Stock News - StockTitan
Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025 - Insider Monkey
H.C. Wainwright analysts reiterates a Buy rating for Microbot Medical Inc (MBOT) - Knox Daily
Microbot Medical regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
Microbot Medical approves special CEO bonus - MSN
HC Wainwright Forecasts Strong Price Appreciation for Microbot Medical (NASDAQ:MBOT) Stock - Defense World
Microbot Medical stock target raised to $9 by H.C. Wainwright - MSN
Microbot Medical Authorizes Special Bonus for CEO - Defense World
Microbot Medical approves special CEO bonus By Investing.com - Investing.com South Africa
Day Trading Grandpa Loses Microbot Short Swing Harm Appeal (1) - Bloomberg Law
Microbot Medical (NASDAQ: MBOT) Appoints Director of Operations to Strengthen Production Efficiencies - Defense World
Microbot Medical Strengthens Its Management Team - citybiz
Microbot Medical Appoints New Director of Operations - TipRanks
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY® - GlobeNewswire
Microbot Medical Strengthens Leadership Team Ahead of LIBERTY Robot Launch in 2025 - StockTitan
Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Update - Defense World
Microbot Medical Appoints David J. Wilson to the Board of Directors - citybiz
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors - The Manila Times
Microbot Medical Names Former J&J Cordis President David Wilson to Board Ahead of LIBERTY Launch - StockTitan
Microbot Medical (NASDAQ: MBOT) Announces $8.6 Million Registered Direct Offering - Defense World
Contrasting Microbot Medical (NASDAQ:MBOT) and CVR Medical (OTCMKTS:CRRVF) - Defense World
Microbot Medical Closes $8.6 Million Registered Direct Offering - citybiz
Microbot Medical closes $8.6M registered direct offering - TipRanks
Microbot Medical Secures $8.6M Funding to Advance LIBERTY® Robotic System Development - StockTitan
Microbot Medical (NASDAQ: MBOT) Enters into ATM Agreement; Provides Intellectual Property UpdateMicrobot Medical Inc. recently disclosed the details of the At-the-Market Offering Agreement (ATM Agreement) entered into with H.C. Wainwright & Co. LLC. - Defense World
Microbot Medical prices 3.79M shares at $2.27 in registered direct offering - Yahoo Finance
Microbot Medical Announces $7 Million Registered Direct Offering - Defense World
Microbot Medical announces $8.6M registered direct offering - MSN
Microbot Medical Raises $8.6M in Direct Offering to Advance LIBERTY® Robotic System Development - StockTitan
Microbot Medical Stock Slides From 52-Week High - MarketWatch
Microbot Medical Raises a Total of Approximately $11.8 - GlobeNewswire
Microbot Medical Secures $11.8M Funding to Advance LIBERTY® Robotic System Development - StockTitan
Form 424B5 Microbot Medical Inc. - StreetInsider.com
SEC Form 424B5 filed by Microbot Medical Inc. - Quantisnow
Microbot Medical concludes at-the-market offering By Investing.com - Investing.com Australia
MBOT stock touches 52-week high at $2.76 amid market optimism - Investing.com Nigeria
Microbot Medical announces $7M offering to support surgical robot commercialization - Mass Device
Microbot Medical Trades at 52-Week High After Direct Offering - MarketWatch
Microbot Medical concludes at-the-market offering - Investing.com India
Microbot (MBOT) Capture Pre-Market Surge With An Equity Move - Stocks Telegraph
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewswire
Microbot Medical Raises $7M Through Direct Offering to Advance LIBERTY® Robotic System - StockTitan
US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025 - Benzinga
Another Robotics Stock on the Move; Microbot Medical Inc. (Nasdaq: MBOT) - Investorideas.com newswire
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):